Do we need defibrillation threshold testing?: A pilot study
| Autor: | Radmila Karan, Natasa Kovacevic-Kostic, G. Milasinovic, Biljana Obrenovic-Kircanski, Mile Vranes, Predrag Mitrovic, Milos Velinovic |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
inorganic chemicals
medicine.medical_specialty implantable cardioverter defibrillator Ventricular Tachyarrhythmias medicine.medical_treatment primary prevention heart failure sudden cardiac death General Biochemistry Genetics and Molecular Biology Standard procedure Sudden cardiac death Defibrillation threshold Primary prevention Internal medicine medicine lcsh:QH301-705.5 treatment business.industry medicine.disease Implantable cardioverter-defibrillator lcsh:Biology (General) Heart failure Cardiology General Agricultural and Biological Sciences business defibrillation threshold testing |
| Zdroj: | Archives of Biological Sciences, Vol 65, Iss 2, Pp 465-474 (2013) |
| ISSN: | 1821-4339 0354-4664 |
| DOI: | 10.2298/abs1302465k |
| Popis: | Defibrillation threshold testing (DFT) is a standard procedure during implantable cardioverter defibrillator (ICD) implantation, however, it is not without risks. We compared the one-year follow-up period in ICD-implanted patients, with and without DFT performed during implantation, for preventive indication in regard to appropriate and inappropriate ICD detection and therapy. One group consisted of 20 patients without DFT; another was comprised of 20 patients where DFT had been performed. There was no difference in the development of ventricular tachyarrhythmias between the groups. Appropriate therapy of ICD was 100%. DFT is not a predictor for successful ICD detection and therapy of ventricular tachyarrhythmias. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|